SO
HARP

STRS Ohio’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

STRS Ohio’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,560
Closed -$127K – 2362
2022
Q1 		$127K Hold
2,560
– – ﹤0.01% 1800
2021
Q4 		$193K Hold
2,560
– – ﹤0.01% 1747
2021
Q3 		$202K Hold
2,560
– – ﹤0.01% 1766
2021
Q2 		$355K Buy
2,560
+1,270
+98% +$242K ﹤0.01% 1667
2021
Q1 		$269K Hold
1,290
– – ﹤0.01% 1745
2020
Q4 		$214K Hold
1,290
– – ﹤0.01% 1725
2020
Q3 		$219K Hold
1,290
– – ﹤0.01% 1645
2020
Q2 		$214K Buy
+1,290
New +$201K ﹤0.01% 1623

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

STRS Ohio's HARP Position: Q2 2022 in Review

STRS Ohio sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2022, closing a stake of 2,560 shares — an estimated $127K sold.

STRS Ohio first reported a position in HARP in Q2 2020 and held it in 8 quarters. The position peaked at $355K in Q2 2021. 63 funds tracked by Wall St. Rank hold HARP as of Q2 2022.

  • STRS Ohio reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • STRS Ohio sold 2,560 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $127K.
  • STRS Ohio first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
  • STRS Ohio's Harpoon Therapeutics, Inc. Common Stock position peaked at $355K in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2022.

Based on STRS Ohio's 13F filing for Q2 2022, filed 25 Jul 2022.